The future of healthcare

The future of healthcare is coming, and three shifts will lead it in the industry. This article recaps research from Gartner, a global information technology company that provides insights on IT-related topics for business decision-makers. The first shift is the emergence of digital health systems, which are projected to account for more than four out of five medical devices sold by 2021. These digital health systems will make up nearly $100 billion in global revenues by 2020 and represent an increasingly large percentage of total device sales revenue at higher levels.

The second shift is the rise of health-related IoT devices, which will reach 20.28 billion units by 2021, with penetration in this market increased from about 12 per cent in 2016 to more than 50 per cent by 2020. This trend will also lead to stronger overall medical device markets, including physical healthcare products and services for both patients and providers alike. Finally, there’s an increased focus on digital disease management solutions designed specifically around support programs aimed at patient populations suffering from chronic conditions like diabetes or heart failure.

These solutions are forecast to grow from $13.92 billion in 2016 to $40.85 billion by 2021, a CAGR of 23 per cent. These three shifts paint a clear picture of the future of healthcare – one that is increasingly reliant on digital systems and devices to manage patient populations and improve care outcomes. Healthcare providers need to start preparing for these changes if they want to stay ahead of the curve.

The emergence of digital health systems will lead to stronger overall medical device markets, including physical healthcare products and services for both patients and providers alike. The rise of health-related IoT devices will reach 20.28 billion units by 2021, with penetration in this market from about 12 per cent in 2016 to more than 50 per cent by 2020.

There’s an increased focus on digital disease management solutions designed specifically around support programs aimed at patient populations suffering from chronic conditions like diabetes or heart failure. These solutions are forecast to grow from $13.92 billion in 2016 to $40.85 billion by 2021, a CAGR of 23 per cent. Connect with Mahmoud Khattab on Linkedin